Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Das P, et al. Among authors: chang gj. Am J Clin Oncol. 2006 Jun;29(3):219-24. doi: 10.1097/01.coc.0000214930.78200.4a. Am J Clin Oncol. 2006. PMID: 16755173
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Krishnan S, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71. doi: 10.1016/j.ijrobp.2006.05.063. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011451 Clinical Trial.
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Das P, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1378-83. doi: 10.1016/j.ijrobp.2006.07.1374. Epub 2006 Oct 23. Int J Radiat Oncol Biol Phys. 2006. PMID: 17056196
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Das P, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):794-800. doi: 10.1016/j.ijrobp.2006.12.052. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379452 Clinical Trial.
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.
Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Yu TK, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1175-80. doi: 10.1016/j.ijrobp.2007.11.018. Epub 2008 Jan 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18207667 Free PMC article. Clinical Trial.
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course.
Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Herman MP, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):818-23. doi: 10.1016/j.ijrobp.2008.08.054. Epub 2009 Jan 13. Int J Radiat Oncol Biol Phys. 2009. PMID: 19147305 Free PMC article.
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Crane CH, et al. Among authors: chang gj. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):824-30. doi: 10.1016/j.ijrobp.2009.02.037. Epub 2009 May 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 19464823 Clinical Trial.
500 results